52 Week Trial of Liraglutide in Type 1 Diabetes

NCT01787916 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Liraglutide
DRUG: Placebos

Sponsor

CHU de Quebec-Universite Laval

Collaborators

[object Object]